publication venue for
- Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients.. 11. 2024
- Reductions in renin-angiotensin system inhibitors following hospitalization for heart failure.. 11. 2024
- Effects of pharmacological interventions on mortality in patients with Takotsubo syndrome: a report from the SWEDEHEART registry.. 11. 2024
- Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial).. 10. 2023
- The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failure.. 9. 2022
- Assessment of cardiac recovery in patients supported with venoarterial extracorporeal membrane oxygenation. 2022
- Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease.. 9. 2022
- Pressure-based estimation of right ventricular ejection fraction.. 9. 2022
- Regional left ventricular systolic dysfunction associated with critical illness: incidence and effect on outcome.. 8. 2021
- Sacubitril/valsartan decreases mortality in the rat model of the isoprenaline-induced takotsubo-like syndrome.. 8. 2021
- A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre.. 8. 2021
- Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof-of-concept study.. 8. 2021
- Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome.. 8. 2021
- The effect of transfusion of blood products on ventricular assist device support outcomes.. 7. 2020
- The importance of heart rate in isoprenaline-induced takotsubo-like cardiac dysfunction in rats.. 7. 2020
- Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.. 6. 2019
- Use of the Palliative Performance Scale to estimate survival among home hospice patients with heart failure.. 6. 2019
- Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome.. 4. 2017
- Reply to: "Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!". 2022